Filing Details

Accession Number:
0001708138-20-000030
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-03 16:50:23
Reporting Period:
2020-04-01
Accepted Time:
2020-04-03 16:50:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585160 E Robert Landry 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Finance Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-04-02 69 $495.24 25,092 No 4 S Direct
Common Stock Disposition 2020-04-02 11 $496.28 25,081 No 4 S Direct
Common Stock Disposition 2020-04-02 25 $497.48 25,056 No 4 S Direct
Common Stock Disposition 2020-04-03 121 $489.50 24,935 No 4 S Direct
Common Stock Disposition 2020-04-03 50 $490.66 24,885 No 4 S Direct
Common Stock Disposition 2020-04-03 25 $492.76 24,860 No 4 S Direct
Common Stock Disposition 2020-04-03 99 $493.51 24,761 No 4 S Direct
Common Stock Disposition 2020-04-03 172 $494.42 24,589 No 4 S Direct
Common Stock Disposition 2020-04-03 2 $495.56 24,587 No 4 S Direct
Common Stock Disposition 2020-04-03 54 $496.33 24,533 No 4 S Direct
Common Stock Disposition 2020-04-03 25 $497.60 24,508 No 4 S Direct
Common Stock Disposition 2020-04-03 62 $498.80 24,446 No 4 S Direct
Common Stock Disposition 2020-04-03 73 $499.37 24,373 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-01 2,500 $0.00 2,500 $272.70
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-01 2,000 $0.00 2,000 $272.70
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-01 1,500 $0.00 1,500 $272.70
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-04-02 3,000 $0.00 3,000 $272.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,000 2023-09-09 No 4 M Direct
50,000 2023-09-09 No 4 M Direct
48,500 2023-09-09 No 4 M Direct
45,500 2023-09-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 172 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 69 shares of Company stock on April 2, 2020 at prices ranging from $495.15 to $495.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 2, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 50 shares of Company stock on April 3, 2020 at prices ranging from $490.45 to $490.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 99 shares of Company stock on April 3, 2020 at prices ranging from $493.02 to $493.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 172 shares of Company stock on April 3, 2020 at prices ranging from $494.01 to $494.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 25 shares of Company stock on April 3, 2020 at prices ranging from $497.35 to $497.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 62 shares of Company stock on April 3, 2020 at prices ranging from $498.77 to $498.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 73 shares of Company stock on April 3, 2020 at prices ranging from $499.09 to $499.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 3, 2020 at each separate price.
  9. The stock option award vests in four equal annual installments, commencing one year after the date of grant.
  10. Form two of two